Compare Costco Wholesale Corporation (COST) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Costco Wholesale Corporation vs 10X Genomics Inc — how do they compare? Costco Wholesale Corporation trades at $945.76 (market cap $420.05B), while 10X Genomics Inc trades at $84.15 (market cap $10.07B). The key difference: Costco Wholesale Corporation is far larger — about 41.7× 10X Genomics Inc's market cap, and Costco Wholesale Corporation pays a 0.62% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Costco Wholesale Corporation for 132 Days and 10X Genomics Inc for 92 Days on average.
| COST | TXG | |
|---|---|---|
Market Cap | $420.05B | $10.07B |
Volume | 2,087,565 | 5,657,286 |
Sector | Consumer Staples | Health |
52-Week High | $1.09K | $97.74 |
52-Week Low | $849.63 | $11.48 |
Typical Hold Time | 132 Days | 92 Days |
Enterprise Value | $407.33B | $9.59B |
Dividend Yield | 0.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Costco (COST) trades at $942.25, up 0.7% on the day, showing strong operational momentum with a 28.4% ROE and 11.3% March sales growth. The stock is near its 52-week high, supported by bullish moving averages, though RSI levels indicate potential overbought conditions. Recent membership fee hikes and robust cash flow generation underscore its resilient business model.
Outlook remains positive given analyst consensus and a $1,090 price target, but elevated P/E of 45.66 poses valuation risk. Key catalysts include sustained membership growth and expansion, while risks involve competitive pressures and macroeconomic sensitivity.
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
